- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01602237
Preventing Respiratory Health Problems in Bakery Employees (Baker2012)
Preventing Respiratory Health Problems in Bakery Employees.
Study Overview
Status
Conditions
Detailed Description
Background and Methods:
Supported by the The Confederation of Norwegian Enterprise (CNBI) Working Environment Fund a follow-up study of 184 bakery workers in 5 bakeries was done in 2012, appr. 10 years after a similar study in 1999-2002. In addition a cross-sectional study in 2 other bakeries (one 'bread-factory', and a traditional bakery with three small bake shops) was added.
Altogether 253 participants, among them 61 former bakery workers, were investigated with use of questionnaires, allergy-testing (skin prick testing, and blood samples for specific IgE and total IgE), spirometry with reversibility testing, exhaled NO-measurement, and nasal measurements.
As in 1999-2002 an extensive exposure assessment was performed including personal samples of total dust (Gelman), inhalable dust (PAS6), as well as direct reading measurements of dust (Dust Track). A Job Exposure Matrix (JEM) was created enabling each participant to be assigned an exposure value of probable mean daily flour-dust exposure based on work-tasks and bakery.
Aim of study:
- Follow-up of the participants in the 1999-2002 study, both still active bakery workers and former workers, on health-status focusing on respiratory disease, sensitization to common and occupational allergens, level of sick-leave and reasons for quitting as a baker.
- Inclusion of 'new' bakery workers into the cohort as a cross-sectional study, and to compare health-status in two cross-sectional cohorts.
- To assess personal exposure to flour-dust among workers in 7 bakeries, as part of the cross-sectional study described above.
- To identify implemented flour-dust exposure reduction measures in bakeries participating in 1999-2002, and to assess the potential impact of these measures on the exposure to flour dust.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bergen, Norway, 5021
- Dept. of Occupational Medicine, Haukeland University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
- All the employees in 5 bakeries investigated in 1999-2002 (one of the original 6 bakeries has fused with one of the others)
- All the employees in additional 2 bakeries located in the same Hordaland county, Norway, as the other 5 bakeries
Description
Inclusion Criteria:
- Employed in a bakery for more than 6 months
- and/or participant of the investigations done in 1999-2002 in 6 bakeries
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Bakery workers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Forced Exhaled Volume in one second (FEV1)
Time Frame: Change/decline from 1999-2002 to 2012
|
The decline in FEV1 from 1999-2002 to 2012.
|
Change/decline from 1999-2002 to 2012
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Forced Vital Capacity (FVC)
Time Frame: Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
|
Before and after salbutamol-inhalation.
Post-bronchodilatory measurements of FEV1 and FVC to measure the prevalence of chronic obstructive lung disease in a cohort of bakery workers
|
Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
|
|
Inflammation markers in nasal lavage
Time Frame: Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
|
Measurement in nasal lavage of inflammation markers (albumin, tryptase, eosinophilic cationic protein) when at work (field study)
|
Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
|
|
Specific IgE
Time Frame: Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
|
In serum measurement of specific IgE to common airborne allergens, and allergens mainly found in bakeries
|
Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
|
|
Skin reaction to prick testing with allergen extracts
Time Frame: Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
|
Skin prick test with commercially available allergen extracts (common and occupational allergens in bakeries)
|
Each participant will be investigated once. Anticipated recruitment time for the whole cohort (study population I and II): about 10 months.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Torgeir Storaas, PhD, MD, Haukeland University Hospital
- Study Director: Tor B Aasen, MD, Haukeland University Hospital
Publications and helpful links
General Publications
- Storaas T, Irgens A, Florvaag E, Steinsvag SK, Ardal L, Do TV, Greiff L, Aasen TB. Bronchial responsiveness in bakery workers: relation to airway symptoms, IgE sensitization, nasal indices of inflammation, flour dust exposure and smoking. Clin Physiol Funct Imaging. 2007 Sep;27(5):327-34. doi: 10.1111/j.1475-097X.2007.00755.x.
- Storaas T, Ardal L, Van Do T, Florvaag E, Steinsvag SK, Irgens A, Aasen TB, Greiff L. Nasal indices of eosinophilic and exudative inflammation in bakery-workers. Clin Physiol Funct Imaging. 2007 Jan;27(1):23-9. doi: 10.1111/j.1475-097X.2007.00707.x.
- Storaas T, Steinsvag SK, Florvaag E, Irgens A, Aasen TB. Occupational rhinitis: diagnostic criteria, relation to lower airway symptoms and IgE sensitization in bakery workers. Acta Otolaryngol. 2005 Nov;125(11):1211-7. doi: 10.1080/00016480510044205.
- Kirkeleit J, Hollund BE, Riise T, Eduard W, Bratveit M, Storaas T. Bakers' exposure to flour dust. J Occup Environ Hyg. 2017 Feb;14(2):81-91. doi: 10.1080/15459624.2016.1225156.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011/2449
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rhinitis
-
Inimmune CorporationRho, Inc.CompletedAllergic Rhinitis | Rhinitis Allergic | Allergic Rhinitis Due to AllergensCanada
-
Liaquat University of Medical & Health SciencesUniversity of Urbino "Carlo Bo"CompletedVasomotor RhinitisItaly
-
Polyrizon Ltd.Not yet recruitingAllergic Rhinitis | Seasonal Allergic Rhinitis (SAR)
-
Shanghai Chia Tai Tianqing Pharmaceutical Technology...RecruitingSeasonal Allergic RhinitisChina
-
Universitaire Ziekenhuizen KU LeuvenAZ Sint-Jan AVRecruitingPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis | Local Allergic RhinitisBelgium
-
Chengdu Kangnuoxing Biopharma,Inc.Not yet recruitingSeasonal Allergic Rhinitis (SAR)China
-
ALK-Abelló A/SCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
Organon and CoCompletedPerennial Allergic Rhinitis | Seasonal Allergic Rhinitis
-
Kazakh National Agrarian UniversityNot yet recruitingRhinitis AllergicKazakhstan
-
Winclove B.V.AlyatecRecruitingPerennial Allergic RhinitisFrance